MIAMI, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular…
NEW YORK, Dec. 19, 2024 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a new daily…